This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, B. Articles by Li, Z. Search for Related Content PubMed PubMed Citation Articles by Liu, B. Articles by Li, Z.

Minireview

Overcoming Immune Tolerance to Cancer by Heat Shock Protein Vaccines ¹

Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, Farmington, Connecticut 06030-1601

Heat shock proteins (HSPs) are a large family of inducible but also ubiquitously and constitutively expressed protein chaperones involved in assisting protein folding and unfolding in the cells. The realization of the immunological significance of HSPs came from the observation that tumor cell-derived HSPs could immunize against tumors, although there were no structural differences between HSPs from normal cells and from cancer cells. Studies of this puzzle have uncovered two unique immunological properties of HSPs. One is their ability to associate and present antigenic fingerprints/peptides of cells to MHC antigens. The other is their ability to activate dendritic cells (DCs), which are the most efficient antigen-presenting cells. These surprising immunological attributes of HSPs are now the basis for a number of already completed clinical trials for cancer immunotherapy. Because DCs orchestrate both innate and adaptive immunity, the findings that HSPs can modulate the functions of DCs may have fundamental implications. We hypothesize that HSPs are at the forefront in counterbalancing T-cell tolerance to tumor-associated antigens and thus play pivotal roles in antitumor immunity in vivo.

This article has been cited by other articles:

				H. Geng, G.-M. Zhang, D. Li, H. Zhang, Y. Yuan, H.-G. Zhu, H. Xiao, L.-F. Han, and Z.-H. Feng Soluble Form of T Cell Ig Mucin 3 Is an Inhibitory Molecule in T Cell-Mediated Immune Response J. Immunol., February 1, 2006; 176(3): 1411 - 1420. [Abstract] [Full Text] [PDF]

				B. Liu, J. Dai, H. Zheng, D. Stoilova, S. Sun, and Z. Li Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases PNAS, December 23, 2003; 100(26): 15824 - 15829. [Abstract] [Full Text] [PDF]